您要查找的是不是：
- inclusion cell disease I-细胞病
- How was sickle cell disease first noted? 镰状细胞病最初是如何发现?
- Can tourniquets be used in patients with sickle cell disease? 止血带能否用于镰状细胞病患者?
- Are there other novel ways of treating sickle cell disease? 治疗镰状细胞病有没有其它新方法?
- What is hemoglobin F, and how does it affect sickle cell disease? 何谓血红蛋白F?其对镰状细胞病有何作用?
- Are patients with sickle cell disease at greater risk of infection? 镰状细胞病患者是否有更高的感染机会?
- How does hydration assist patients with sickle cell disease? 水合作用（液体治疗）用于镰状细胞病治疗的原因?
- What is responsible for the "anemia" of sickle cell disease? 镰状细胞病“贫血”的原因?
- Is supplemental oxygen beneficial for patients with sickle cell disease? 辅助供氧对镰状细胞病患者是否有益?
- When should transfusions be considered in patients with sickle cell disease? 镰状细胞病患者什么情况下考虑输血?
- Transfusions are usually not required nor recommended for standard aso-occlusie crises or pain associated with sickle cell disease. 对于镰状细胞病相关的标准血管阻塞性危象或疼痛，输血治疗常没有必要，且不推荐使用。
- Longitudinal decline in lung volume in a population of children with sickle cell disease. 在患镰状红细胞性贫血的儿童人群中，肺容量呈纵向下降。
- Transfusions hae been ealuated to treat certain seere complications of sickle cell disease. 通过输血治疗镰状细胞病的一些严重的并发症。
- Transfusions have been evaluated to treat certain severe complications of sickle cell disease. 通过输血治疗镰状细胞病的一些严重的并发症。
- Sickle cell disease is any sickle cell disorder in which significant morbidity occurs, such as vaso-occlusive pain crisis (VPC) or organ dysfunction. 镰状细胞病是一类高死亡率的镰状细胞紊乱，如血管阻塞性疼痛危象（VPC）或器官功能紊乱。
- Transfusions are usually not required nor recommended for standard vaso-occlusive crises or pain associated with sickle cell disease. 对于镰状细胞病相关的标准血管阻塞性危象或疼痛，输血治疗常没有必要，且不推荐使用。
- Sickle cell disease is any sickle cell disorder in which significant morbidity occurs, such as aso-occlusie pain crisis (PC) or organ dysfunction. 镰状细胞病是一类高死亡率的镰状细胞紊乱，如血管阻塞性疼痛危象（PC）或器官功能紊乱。
- In fact, the lifespan of erythrocytes in sickle cell disease has been obsered to be only 10-12 days, compared to the normal 120 days (4). 事实上，据观察，镰状细胞病红细胞的寿命只有10-12天，而正常红细胞的寿命为120天[4]。
- Hydroxyurea has been observed to increase the level of hemoglobin F, and has been used with some success in reducing the morbidity of sickle cell disease (2). 羟基脲有增加血红蛋白F水平的功能，并被成功地用于部分镰状细胞病患者的治疗，减低了死亡率[2]。
- Conclusions: Untreated asymptomatic osteonecrosis of the femoral head in patients with sickle cell disease has a high likelihood of progression to pain and collapse. 结论：镰形细胞病所致无症状性股骨头坏死的患者若未经合理处理，有很大可能性发展为疼痛和股骨头塌陷。
